Dietary Fat Increases Energy Intake Across the Range of Typical Consumption in the United States

Kaiser Permanente Colorado, Denver, Colorado, USA.
Obesity (Impact Factor: 3.73). 02/2008; 16(1):64-9. DOI: 10.1038/oby.2007.31
Source: PubMed


The fat content of a diet has been shown to affect total energy intake, but controlled feeding trials have only compared very high (40% of total calories) fat diets with very low (20% of total calories) fat diets. This study was designed to measure accurately the voluntary food and energy intake over a range of typical intake for dietary fat.
Twenty-two non-obese subjects were studied for 4 days on each of three diets, which included core foods designed to contain 26, 34, and 40% fat, respectively of total calories and ad lib buffet foods of similar fat content. All diets were matched for determinants of energy density except dietary fat. Subjects consumed two meals/day in an inpatient unit and were provided the third meal and snack foods while on each diet. All food provided and not eaten was measured by research staff.
Voluntary energy intake increased significantly as dietary fat content increased (P = 0.008). On the 26% dietary fat treatment, subjects consumed 23.8% dietary fat (core and ad lib foods combined) and 2,748 +/- 741 kcal/day (mean +/- s.d.); at 34% dietary fat, subjects consumed 32.7% fat and 2,983 +/- 886 kcal/day; and at 40% dietary fat subjects consumed 38.1% fat and 3,018 +/- 963 kcal/day.
These results show that energy intake increases as dietary fat content increases across the usual range of dietary fat consumed in the United States. Even small reductions in dietary fat could help in lowering total energy intake and reducing weight gain in the population.

Download full-text


Available from: James O Hill, Dec 14, 2014
  • Source
    • "could be a preferred are high in fat and sugars (Donahoo et al., 2008). ADHD patients choose for the immediate choice when faced with a choice between immediacy and delay (Banaschewski et al., 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Attention deficit hyperactivity disorder (ADHD) is a common child diagnosis with frequent comorbidities (Quinn, 2008). According to present studies eating disorders may represent one of them (Mikami et al., 2008). Several studies reported ADHD relation to the higher predisposition to obesity (Altafas, 2002), higher values of signs of overnutrition, as body mass index (Waring and Lapane, 2008) or higher value of fat (Ptacek et al., 2009a, c). These characteristics are considered to be directly related to the disorder. They can be caused by impulsivity and probable specific feeding customs of ADHD patients. The presence of eating disorders in ADHD patients could partially explain previously described growth and weight changes.
    Prague medical report 01/2010; 111(3):175-81.
  • Source
    • "Because dietary fat is the most obesity-promoting macronutrient it has been identified as an important causal factor in the obesity epidemic (Donahoo, Wyatt et al. 2008). Therefore, understanding the processes by which dietary fat intake is regulated and how these mechanisms malfunction in our modern environment may lead to new therapeutic options for the treatment of obesity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: N-acylphosphatidylethanolamines (NAPEs) are a relatively abundant group of plasma lipids of unknown physiological significance. Here, we show that NAPEs are secreted into circulation from the small intestine in response to ingested fat and that systemic administration of the most abundant circulating NAPE, at physiologic doses, decreases food intake in rats without causing conditioned taste aversion. Furthermore, (14)C-radiolabeled NAPE enters the brain and is particularly concentrated in the hypothalamus, and intracerebroventricular infusions of nanomolar amounts of NAPE reduce food intake, collectively suggesting that its effects may be mediated through direct interactions with the central nervous system. Finally, chronic NAPE infusion results in a reduction of both food intake and body weight, suggesting that NAPE and long-acting NAPE analogs may be novel therapeutic targets for the treatment of obesity.
    Cell 12/2008; 135(5):813-24. DOI:10.1016/j.cell.2008.10.043 · 32.24 Impact Factor
  • Source

    Obesity 02/2008; 16(1):5-6. DOI:10.1038/oby.2007.52 · 3.73 Impact Factor
Show more